Seer, Inc.
A life sciences company that develops products for proteomics research.
SEER | US
Overview
Corporate Details
- ISIN(s):
- US81578P1066
- LEI:
- Country:
- United States of America
- Address:
- 3800 BRIDGE PARKWAY, SUITE 102, 94065 REDWOOD CITY
- Website:
- https://seer.bio/
Description
Seer, Inc. is a life sciences company that develops and commercializes products to advance proteomics research. The company's core offering is the Proteograph Product Suite, an integrated platform designed to provide deep, unbiased, and large-scale access to the proteome. Utilizing proprietary engineered nanoparticles, Seer's technology enables researchers to analyze complex biological samples with high throughput, speed, and reproducibility. This approach facilitates the comprehensive detection of proteins, including those at low abundance that are critical for understanding disease and health states. The platform is complemented by the Proteograph Analysis Suite, a software solution for data analysis and biomarker discovery. Seer aims to empower the scientific community with tools to overcome technological barriers in proteomics, accelerating insights in precision medicine and human biology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Seer, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Seer, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Seer, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||